Gilead Sciences Inc. GILD, -1.15% announced Tuesday an agreement to purchase a 49.9% stake in private cancer treatment developer Tizona Therapeutics Inc. for $ 300 million. Gilead also received the option to purchase the rest of Tizona for up to an additional $ 1.25 billion, including possible future milestone payments. …
Read More »
Gilead Sciences Inc. GILD, -1.29% announced Tuesday an agreement to purchase a 49.9% stake in private cancer treatment developer Tizona Therapeutics Inc. for $ 300 million. Gilead also received the option to purchase the rest of Tizona for up to an additional $ 1.25 billion, including possible future milestone payments. …
Read More »
JMP Securities analyst Joseph Osha downgraded Tesla Inc.’s TSLA rating, + 9.47% for the market to outperform the market on Tuesday, the day before the company reports second-quarter earnings. “The company’s valuation now slightly exceeds the $ 1,500 price target we recently set, and we believe that any medium-term success …
Read More »
Small Cap Shares Moleculin Biotech Inc. MBRX, + 3.77% A 43% surge in pre-market trade Tuesday, after the company said a second round of laboratory tests confirmed antiviral activity for WP1122, its candidate for treatment for COVID-19. The laboratory involved was the IIT Research Institute, an affiliate of the Illinois …
Read More »
Networking site LinkedIn is cutting around 960 jobs, or 6% of its workforce, as it moves to align business with the new world COVID-19. In a message posted on the website of the Microsoft Corp.-owned company, Chief Executive Ryan Roslanksy said LinkedIn is not immune to the effects of the …
Read More »